#$%^&*AU2011101627B420120216.pdf#####ABSTRACT A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically 5 effective amount of VEGF antagonist. 30108W_1 (GHMatter) P71783 AU 4 .Do1 I